REQUEST A DEMO
Total
USD $0.00
Search more companies

White Line Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: White Line Pharma Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

White Line Pharma Private Limited is an enterprise in India, with the main office in Wayanad. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on December 21, 2001. From the latest financial highlights, White Line Pharma Private Limited reported a net sales revenue increase of 11.83% in 2025. Its total assets grew by 3.38% over the same period. White Line Pharma Private Limited’s net profit margin increased by 0.04% in 2025.

Legal Address
Door No.Xiii/897(3), Sakthi Arcade Leo Hospital Road,Vythiri Taluk
Wayanad; Kerala; Postal Code: 673121

Contact Details: Purchase the White Line Pharma Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the White Line Pharma Private Limited report to view the information.
Financial Auditors:
Purchase the White Line Pharma Private Limited report to view the information.
Incorporation Date:
December 21, 2001
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after White Line Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
11.83%
Total Operating Revenue
11.84%
Operating Profit
8.48%
EBITDA
6.14%
Net Profit/Loss for the Period
15.92%
Total Assets
3.38%
Total Equity
14.79%
Operating Profit Margin
-0.12%
Net Profit Margin
0.04%
Return on Equity (ROE)
0.12%
Debt / Equity
-29%
Quick Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?